Modulation of renin-angiotensin system and arterial stiffness: Evidence from clinical trials

Current Hypertension Reviews

Volumn 10, Issue 1, 2014, Pages 37-40

  Sohn, Il Suk ^a   Kim, Chong Jin ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Arterial stiffness; Cardiovascular disease; Clinical trias; Hypertension; Rennin angiotensin system

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; AZELNIDIPINE; BENDROFLUMETHIAZIDE; BISOPROLOL; CAPTOPRIL; EPLERENONE; FOSINOPRIL; HYDROCHLOROTHIAZIDE; INDAPAMIDE; ISRADIPINE; LACIDIPINE; LERCANIDIPINE; LISINOPRIL; LOSARTAN; METOPROLOL; NEBIVOLOL; NIFEDIPINE; NITRENDIPINE; OLMESARTAN; PERINDOPRIL; PROPRANOLOL; QUINAPRIL; RAMIPRIL; SPIRONOLACTONE; TELMISARTAN; TRANDOLAPRIL; VALSARTAN; VERAPAMIL;

ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL (TOPIC); ESSENTIAL HYPERTENSION; HUMAN; MODULATION; PATHOGENESIS; PRIORITY JOURNAL; PULSE WAVE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; CARDIOVASCULAR DISEASES; DRUG EFFECTS; HYPERTENSION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; HUMANS; HYPERTENSION; RENIN-ANGIOTENSIN SYSTEM; VASCULAR STIFFNESS;

EID: 84926344572     PISSN: 15734021     EISSN: 18756506     Source Type: Journal    
DOI: 10.2174/157340211001141111160311     Document Type: Article

References (24)

1. Rhee MY, Lee HY, Park JB. Measurements of arterial stiffness: Methodological aspects. Korean Circ J 2008; 38: 343-50.
2. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-41.
3. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33: 1111-7.
4. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: A systematic review and meta-analysis. J Am Coll Cardiol 2010; 55: 1318-27.
5. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the european society of cardiology (ESC). European heart journal 2013; 34: 2159-219.
6. Lakatta EG. Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises: Part iii: Cellular and molecular clues to heart and arterial aging. Circulation 2003; 107: 490-7.
7. Perret-Guillaume C, Joly L, Jankowski P, Benetos A. Benefits of the RAS blockade: Clinical evidence before the ONTARGET study. J Hypertens 2009; 27(2): S3-7.
8. Protogerou AD, Papaioannou TG, Lekakis JP, Blacher J, Safar ME. The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part i: (patho)-physiology, rationale and perspective on pulse pressure amplification. Curr Pharm Des 2009; 15: 267-71.
9. Asmar R. Effect of antihypertensive agents on arterial stiffness as evaluated by pulse wave velocity: Clinical implications. Am J Cardiovasc Drugs 2001; 1: 387-97.
10. Mahmud A, Feely J. Antihypertensive drugs and arterial stiffness. Expert Rev Cardiovasc Ther 2003; 1: 65-78.
11. Takami T, Shigemasa M. Efficacy of various antihypertensive agents as evaluated by indices of vascular stiffness in elderly hypertensive patients. Hypertens Res 2003; 26: 609-14.
12. Williams B, Lacy PS, Thom SM, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the conduit artery function evaluation (CAFE) study. Circulation 2006; 113: 1213-25.
13. Papaioannou TG, Stefanadis C. Central hemodynamics and arterial stiffness: Methodological, clinical and pharmaceutical considerations. Curr Pharm Des 2009; 15: 243-4.
14. Mackenzie IS, McEniery CM, Dhakam Z, Brown MJ, Cockcroft JR, Wilkinson IB. Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension. Hypertension 2009; 54: 409-13.
15. Protogerou A, Blacher J, Stergiou GS, Achimastos A, Safar ME. Blood pressure response under chronic antihypertensive drug therapy: The role of aortic stiffness in the reason (preterax in regression of arterial stiffness in a controlled double-blind) study. J Am Coll Cardiol 2009; 53: 445-51.
16. Mallareddy M, Parikh CR, Peixoto AJ. Effect of angiotensinconverting enzyme inhibitors on arterial stiffness in hypertension: Systematic review and meta-analysis. J Clin Hypertens (Greenwich) 2006; 8: 398-403.
17. Asmar R, Topouchian J, Pannier B, Benetos A, Safar M. Pulse wave velocity as endpoint in large-scale intervention trial. The complior study. Scientific, quality control, coordination and investigation committees of the complior study. J Hypertens 2001; 19: 813-8.
18. Mitchell GF, Dunlap ME, Warnica W, et al. Long-term trandolapril treatment is associated with reduced aortic stiffness: The prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudy. Hypertension 2007; 49: 1271-7.
19. Mahmud A, Feely J. Favourable effects on arterial wave reflection and pulse pressure amplification of adding angiotensin ii receptor blockade in resistant hypertension. J Hum Hypertens 2000; 14: 541-6.
20. Klingbeil AU, John S, Schneider MP, Jacobi J, Weidinger G, Schmieder RE. AT1-receptor blockade improves augmentation index: A double-blind, randomized, controlled study. J Hypertens 2002; 20: 2423-8.
21. Mahmud A, Feely J. Reduction in arterial stiffness with angiotensin II antagonist is comparable with and additive to ACE inhibition. Am J Hypertens 2002; 15: 321-5.
22. Matsui Y, Eguchi K, O'Rourke MF, et al. Hypertension 2009; 54: 716-23.
23. Park CG, Ahn JC, Hong SJ, et al. Efficacy of irbesartan of left ventricular mass and arterial stiffness in hypertensive patients. Korean J Intern Med 2006; 21: 103-8.
24. Jung AD, Kim W, Park SH, et al. The effect of telmisartan on endothelial function and arterial stiffness in patients with essential hypertension. Korean Circ J 2009; 39: 180-4.